Stay updated on Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page has updated its date references, removing older dates and adding new ones, while the address for Hirakata, Japan has been slightly modified in formatting. The changes reflect a shift in time-sensitive information.
    Difference
    0.2%
    Check dated 2025-05-02T23:15:13.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-04-25T20:15:46.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding a Phase 3 clinical trial for amivantamab and the addition of identifiers related to advanced or metastatic non-small cell lung cancer.
    Difference
    11%
    Check dated 2025-04-18T14:31:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The page has removed the phrase 'Last Update Posted (Estimated)' and replaced it with 'Last Update Posted'.
    Difference
    0.0%
    Check dated 2025-04-11T10:47:03.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.4) and includes new dates for updates, while previous dates and the last update version have been removed.
    Difference
    0.2%
    Check dated 2025-04-03T21:50:15.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous version (v2.14.2) and date of March 4, 2025.
    Difference
    0.1%
    Check dated 2025-03-27T14:46:47.000Z thumbnail image

Stay in the know with updates to Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lazertinib vs Intravenous Amivantamab in Lung Cancer Clinical Trial page.